AMASS Electrolyte Mixers hit $429K annual run rate in month 1

1 min read     Updated on 16 Jul 2026, 08:28 PM
scanx
Reviewed by
Riya DScanX News Team
AI Summary

AMASS Brands Group announced that its AMASS Electrolyte Mixers line generated approximately $36,000 in gross revenue in its first full month, translating to an annualized run rate of approximately $429,000. The launch included two limited edition flavors, AMASS Tonic and AMASS Transfusion, which offer reduced sugar content and are formulated with essential electrolytes. The company targets growing markets in tonic water and golf-related beverages.

powered bylight_fuzz_icon
45758958

*this image is generated using AI for illustrative purposes only.

AMASS Brands Group (NASDAQ: AMSS) announced that its AMASS Electrolyte Mixers ready-to-drink line achieved an annualized gross revenue of approximately $429,000 in the first full month following its May 2026 debut. The line generated approximately $36,000 in gross revenue across the company's direct-to-consumer and wholesale channels, supported by an initial distribution partnership in the Midwest. The company also launched two limited edition flavors, AMASS Tonic and AMASS Transfusion, available through its direct-to-consumer channel.

The new flavors are formulated with essential electrolytes and real Pacific sea salt, containing no artificial sweeteners, colors, or flavors. AMASS Tonic delivers 82% less sugar than the leading tonic water mixer, while AMASS Transfusion has 66% less sugar than its leading competitor. Each serving provides 250mg of sodium, 60mg of potassium, and 20mg of magnesium. The drinks are designed for dual use as a standalone beverage or mixer with alcoholic or non-alcoholic spirits.

Market Context

The launch of AMASS Tonic targets the largest tonic water market in the world. North America accounted for 39.4% of global tonic water value in 2024, approximately $0.6 billion. The U.S. and Canada tonic water market is projected to grow from $399 million in 2025 to $655 million by 2032, representing a 7.3% compound annual growth rate.

AMASS Transfusion enters the market amid a record golf boom in the United States. According to the National Golf Foundation, 47.2 million Americans played golf in 2024, up 5% year-over-year and 38% versus pre-pandemic 2019. Rounds played reached a record 545 million.

Flavor Profiles

Flavor Sugar Reduction Key Ingredients Use Case
AMASS Tonic 82% less sugar than leading tonic water Essential electrolytes, real Pacific sea salt Standalone beverage or mixer
AMASS Transfusion 66% less sugar than leading competitor Grape, ginger, essential electrolytes Standalone beverage or mixer

Mark Thomas Lynn, Founder and Chief Executive Officer of AMASS, stated that the company identifies rising occasions and formulates products for them within a season. He emphasized that the agility demonstrated in the first month indicates the potential of the line.

What are AMASS's plans for expanding distribution beyond the initial Midwest partnership to capture a larger share of the North American tonic water market?

Will the company introduce permanent flavor additions to the Electrolyte Mixers line following the performance of these limited edition releases?

How does AMASS intend to leverage the record golf boom to specifically drive sales of the Transfusion flavor in the sports and leisure sector?

like19
dislike

Maxim Group initiates coverage on Amass Brands with Buy rating

0 min read     Updated on 02 Jul 2026, 08:25 PM
scanx
Reviewed by
Radhika SScanX News Team
AI Summary

Maxim Group analyst Thomas Forte initiates coverage on Amass Brands with a Buy rating and sets a price target of $7.

powered bylight_fuzz_icon
44549725

*this image is generated using AI for illustrative purposes only.

Maxim Group analyst Thomas Forte has initiated coverage on Amass Brands with a Buy rating and a price target of $7. The rating reflects a positive outlook on the company's performance and market position.

Coverage Details

The initiation by Maxim Group provides a new benchmark for investors evaluating Amass Brands. The $7 price target suggests potential upside from current trading levels.

Metric Value
Rating Buy
Price Target $7
Coverage Analyst Thomas Forte

Amass Brands is listed on NASDAQ under the ticker symbol AMSS.

What specific growth drivers does Maxim Group anticipate will propel Amass Brands to the $7 price target?

How might this new coverage influence investor sentiment and trading volume for AMSS in the short term?

What competitive advantages does Amass Brands have that justify the Buy rating compared to its peers?

like16
dislike

More News on AMASS Brands Group